Literature DB >> 28608367

The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Alessandra Picardi1, William Arcese1, Simona Pollichieni2, Fabio Di Piazza1, Ilaria Mangione1, Anna Maria Gallina2, Raffaella Cerretti1, Laura Cudillo1, Gottardo De Angelis1, Andrea Mengarelli3, Teresa Dentamaro4, Maria Cristina Tirindelli5, Anna Chierichini6, Antonella Ferrari7, Renato Marciano2, Marco Andreani8, Francesca Bonifazi9, Nicoletta Sacchi2.   

Abstract

BACKGROUND: From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies successfully identified a matched unrelated donor (MUD) through the Italian Bone Marrow Donor Registry (IBMDR), corresponding to a transplant efficiency of 62%. STUDY DESIGN AND METHODS: From 2006, the Rome Transplant Network (RTN) followed a hierarchical selection strategy for the alternative donor search: first MUD, second cord blood, and third haploidentical donor. Using a low-resolution HLA, a preliminary query (PQ) was performed in all cases with assignment of good or poor score if more or less than 10 MUDs were identified in Bone Marrow Donors Worldwide. Herein we assessed the utility of PQ and of high-resolution (HR) HLA from the start of the search. Moreover, we compared the donor identification and the transplant efficiency between IBMDR and RTN.
RESULTS: At RTN 79% of 417 patients met a good PQ with a 50% MUD identification versus 12.5% with poor PQ. Our policy led to 78 and 74% of alternative donor identification and transplant efficiency, respectively, higher than IBMDR data equal to 71% (p = 0.007) and 62% (p < 0.0001). The timing for donor identification was significantly reduced using HR HLA at the start of the search from 88 to 66 days at IBMDR (p < 0.001) and from 61 to 41 days at RTN (p < 0.001).
CONCLUSIONS: Both PQ and HR HLA at the start of the process represents a useful tool to address the search towards the best and timely donor choice. Moreover, establishing a specific donor policy significantly improves the transplant efficiency.
© 2017 The Authors Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.

Entities:  

Mesh:

Year:  2017        PMID: 28608367     DOI: 10.1111/trf.14131

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.

Authors:  A Picardi; M Miranda; F Liciani; G Paterno; W Arcese; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2017-01-21

2.  Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.

Authors:  A Picardi; A S Ferraro; M Miranda; F Meconi; A Lanti; G Adorno; W Arcese; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2017-01-21

3.  Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor.

Authors:  Federico Meconi; Giulia Ciangola; Benedetta Mariotti; Raffaella Cerretti; Laura Cudillo; William Arcese; Alessandra Picardi
Journal:  Case Rep Infect Dis       Date:  2019-09-19

4.  High-resolution analysis of the HLA-A, -B, -C and -DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry.

Authors:  Nicoletta Sacchi; Mauro Castagnetta; Valeria Miotti; Lucia Garbarino; Annamaria Gallina
Journal:  HLA       Date:  2019-07-03       Impact factor: 4.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.